MARKED ENHANCEMENT OF CLINICAL EFFICACY OF PLATELET GP IIB IIIA BLOCKADE WITH C7E3 FAB (ABCIXIMAB) LINKED TO REDUCTION IN BLEEDING COMPLICATIONS - OUTCOME IN THE EPILOG AND EPIC TRIALS/
Am. Lincoff et al., MARKED ENHANCEMENT OF CLINICAL EFFICACY OF PLATELET GP IIB IIIA BLOCKADE WITH C7E3 FAB (ABCIXIMAB) LINKED TO REDUCTION IN BLEEDING COMPLICATIONS - OUTCOME IN THE EPILOG AND EPIC TRIALS/, Circulation, 94(8), 1996, pp. 2185-2185